We have carried out clinical trials that have made it possible to validate rapid detection tests and, thanks to these studies, they are currently used to detect infected people and prevent new outbreaks of the disease.
We have also validated these antigen tests as a method of preventing the transmission of SARS-CoV-2 in cultural activities with a large number of people, conducting clinical trials in spaces such as the Sala Apolo or the Palau Sant Jordi. At the same time, we are also developing a new highly sensitive detection test in collaboration with the Institute of Photonic Sciences (ICFO) and we continue to validate tests that are useful to prevent outbreaks of COVID-19. Being able to detect the infection in very early stages is key to preventing the transmission of the virus among the population and controlling the pandemic. In order to continue with this line of research we need resources, that is why we continue to need your help!